Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES FIDELIO CAPITAL IN CONNECTION WITH NORDIC CAPITAL’S INVEStMENT IN ANICURA
Mandate

VINGE ADVISES FIDELIO CAPITAL IN CONNECTION WITH NORDIC CAPITAL’S INVEStMENT IN ANICURA

July 01, 2014

Vinge advises Fidelio Capital in connection with Nordic Capital’s investment in AniCura. AniCura is owned by a large number of staff, the Foundation Djursjukhus i Stor-Stockholm and the Swedish investment firm Fidelio Capital. All parties will remain significant co-owners together with Nordic Capital. Through Nordic Capital’s co-ownership, resources will be made available for, among other things, establishing a new veterinary specialist neurological centre at AniCura Albano Animal Hospital in Danderyd, Sweden. Nordic Capital’s investment is subject to approval from the relevant competition authorities.

Partners Jonas Bergström and Johan Winnerblad together with, among others, associates Peter Sundgren, Gustav Jönsson, Amanda Winberg, Johan Mattson, Emelie Klefbeck and project assistant Pernilla Warg advises Fidelio Capital. Partner Marcus Glader advises on competition law.

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB

 Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB.
September 18, 2025

Vinge advises Workday, Inc. on its $1.1 billion acquisition of Sana Labs

 Vinge, together with Orrick Herrington & Sutcliffe, has advised Workday, Inc. (NASDAQ: WDAY) (“Workday”) on its acquisition of all shares in Sana Labs AB.
September 16, 2025

Vinge advises on the sale of ArmaTech to Defensor Group

 Vinge has advised on the sale of ArmaTech i Kungsbacka AB (“ArmaTech”) to the newly formed defence group Defensor Group AB (“Defensor”).
September 16, 2025